SAVA
NASDAQ · Pharmaceuticals
Cassava Sciences Inc
$1.18
-0.01 (-0.84%)
Open$1.19
Previous Close$1.19
Day High$1.21
Day Low$1.17
52W High$4.98
52W Low$1.16
Volume—
Avg Volume313.1K
Market Cap114.97M
P/E Ratio—
EPS$-2.20
SectorPharmaceuticals
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 22.84M | 20.47M | 21.96M |
| Net Income | 4.14M | 5.17M | 4.25M |
| Profit Margin | 18.1% | 25.2% | 19.3% |
| EBITDA | 7.09M | 5.98M | 7.27M |
| Free Cash Flow | 3.09M | 2.63M | 3.14M |
| Rev Growth | -6.9% | +1.2% | +18.5% |
| Debt/Equity | 1.35 | 1.36 | 1.39 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,124.85 | +0.68% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $245.14 | +1.72% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $124.71 | +3.41% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $23.83 | -0.87% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.00 | -0.95% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $77.65 | -0.67% | 12.5 | 33.00B |